Raltegravir Combo Gives New Anti-HIV Alternative

BOSTON (MedPage Today) -- The use of a two-drug anti-HIV therapy of raltegravir (Isentress) plus darunavir (Prezista) appeared to be non-inferior to tenofovir/emtricitabine (Truvada) plus darunavir, researchers reported here.
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news